# Abilify Asimtufii

NDC: 59148-102
Generic name: Aripiprazole
Labeler / Manufacturer: Otsuka America Pharmaceutical, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Routes: INTRAMUSCULAR
Marketing started: 20230427

FDA application: NDA217006

## Active ingredients

- ARIPIPRAZOLE: 720 mg/2.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59148-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59148-102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da4c07fd-1130-4341-bb44-63acfa4162be